Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Nalbuphine Hydrochloride Injection

Approval Number

国药准字H20130127

Company宜昌人福药业有限责任公司

Registration Date

August 11, 2023

Drug Information

Generic Name

盐酸纳布啡注射液

Trade Name

瑞静

Dosage Form

注射剂

Strength

2ml:20mg

Drug Type

化学药品

Registration Date

August 11, 2023

Company Information

Applicant Company

Company Name宜昌人福药业有限责任公司

Company Address

湖北省宜昌开发区大连路19号

Manufacturing Company

Company Name宜昌人福药业有限责任公司

Company Address

湖北省宜昌开发区大连路19号；湖北省宜昌市东临路517号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy